Cerus Pre-Tax Profit Margin 2010-2025 | CERS
Cerus pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Cerus Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.21B | $-0.02B | -9.13% |
| 2024-12-31 | $0.20B | $-0.02B | -10.40% |
| 2024-09-30 | $0.20B | $-0.02B | -10.10% |
| 2024-06-30 | $0.19B | $-0.02B | -12.37% |
| 2024-03-31 | $0.19B | $-0.03B | -16.23% |
| 2023-12-31 | $0.19B | $-0.04B | -19.89% |
| 2023-09-30 | $0.18B | $-0.05B | -26.63% |
| 2023-06-30 | $0.18B | $-0.05B | -27.32% |
| 2023-03-31 | $0.18B | $-0.05B | -24.59% |
| 2022-12-31 | $0.19B | $-0.04B | -21.81% |
| 2022-09-30 | $0.19B | $-0.04B | -19.79% |
| 2022-06-30 | $0.18B | $-0.04B | -22.40% |
| 2022-03-31 | $0.17B | $-0.05B | -27.75% |
| 2021-12-31 | $0.16B | $-0.05B | -33.13% |
| 2021-09-30 | $0.14B | $-0.06B | -40.28% |
| 2021-06-30 | $0.13B | $-0.06B | -45.80% |
| 2021-03-31 | $0.12B | $-0.06B | -50.00% |
| 2020-12-31 | $0.12B | $-0.06B | -51.30% |
| 2020-09-30 | $0.11B | $-0.06B | -57.94% |
| 2020-06-30 | $0.10B | $-0.07B | -65.35% |
| 2020-03-31 | $0.10B | $-0.07B | -71.88% |
| 2019-12-31 | $0.09B | $-0.07B | -77.42% |
| 2019-09-30 | $0.09B | $-0.07B | -81.61% |
| 2019-06-30 | $0.08B | $-0.07B | -80.72% |
| 2019-03-31 | $0.08B | $-0.06B | -77.50% |
| 2018-12-31 | $0.08B | $-0.06B | -76.00% |
| 2018-09-30 | $0.07B | $-0.05B | -71.62% |
| 2018-06-30 | $0.07B | $-0.05B | -76.47% |
| 2018-03-31 | $0.06B | $-0.05B | -86.67% |
| 2017-12-31 | $0.05B | $-0.06B | -111.76% |
| 2017-09-30 | $0.04B | $-0.06B | -136.36% |
| 2017-06-30 | $0.04B | $-0.06B | -151.22% |
| 2017-03-31 | $0.04B | $-0.07B | -169.23% |
| 2016-12-31 | $0.04B | $-0.06B | -161.54% |
| 2016-09-30 | $0.04B | $-0.07B | -175.68% |
| 2016-06-30 | $0.04B | $-0.07B | -188.57% |
| 2016-03-31 | $0.04B | $-0.07B | -191.43% |
| 2015-12-31 | $0.04B | $-0.06B | -171.43% |
| 2015-09-30 | $0.04B | $-0.06B | -180.00% |
| 2015-06-30 | $0.04B | $-0.06B | -156.76% |
| 2015-03-31 | $0.04B | $-0.05B | -129.73% |
| 2014-12-31 | $0.04B | $-0.04B | -105.41% |
| 2014-09-30 | $0.04B | $-0.03B | -69.44% |
| 2014-06-30 | $0.04B | $-0.03B | -91.89% |
| 2014-03-31 | $0.04B | $-0.03B | -86.84% |
| 2013-12-31 | $0.04B | $-0.04B | -107.50% |
| 2013-09-30 | $0.04B | $-0.04B | -92.86% |
| 2013-06-30 | $0.04B | $-0.02B | -56.41% |
| 2013-03-31 | $0.04B | $-0.02B | -44.74% |
| 2012-12-31 | $0.04B | $-0.02B | -43.24% |
| 2012-09-30 | $0.04B | $-0.02B | -61.11% |
| 2012-06-30 | $0.04B | $-0.02B | -45.95% |
| 2012-03-31 | $0.04B | $-0.02B | -60.00% |
| 2011-12-31 | $0.03B | $-0.02B | -51.52% |
| 2011-09-30 | $0.03B | $-0.01B | -37.93% |
| 2011-06-30 | $0.03B | $-0.02B | -68.00% |
| 2011-03-31 | $0.02B | $-0.02B | -70.83% |
| 2010-12-31 | $0.02B | $-0.02B | -73.91% |
| 2010-09-30 | $0.02B | $-0.02B | -90.91% |
| 2010-06-30 | $0.02B | $-0.02B | -100.00% |
| 2010-03-31 | $0.02B | $-0.02B | -110.00% |
| 2009-12-31 | $0.02B | $-0.02B | -141.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.256B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.226B | 28.28 |
| Boston Scientific (BSX) | United States | $157.620B | 39.46 |
| Stryker (SYK) | United States | $148.687B | 31.09 |
| EssilorLuxottica (ESLOY) | France | $134.580B | 0.00 |
| Medtronic (MDT) | Ireland | $110.773B | 16.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.060B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.664B | 28.26 |
| ResMed (RMD) | United States | $36.384B | 27.33 |
| GE HealthCare Technologies (GEHC) | United States | $32.899B | 15.62 |
| Agilent Technologies (A) | United States | $32.353B | 21.37 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $23.046B | 90.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.521B | 16.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.865B | 12.12 |
| Baxter (BAX) | United States | $16.144B | 12.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.881B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.316B | 13.41 |
| Prestige Consumer Healthcare (PBH) | United States | $4.327B | 19.33 |
| Perrigo (PRGO) | Ireland | $3.770B | 9.55 |
| Haemonetics (HAE) | United States | $3.462B | 15.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.190B | 15.06 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.80 |
| AtriCure (ATRC) | United States | $1.686B | 0.00 |
| Neogen (NEOG) | United States | $1.346B | 17.22 |
| Kestra Medical Technologies (KMTS) | United States | $1.280B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| BioLife Solutions (BLFS) | United States | $1.083B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.933B | 9.40 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.580B | 0.00 |
| Owens & Minor (OMI) | United States | $0.564B | 4.68 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.503B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.33 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.300B | 53.40 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 22.67 |
| Verano Holdings (VRNOF) | United States | $0.262B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.24 |
| Biote (BTMD) | United States | $0.218B | 6.12 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.45 |
| Quanterix (QTRX) | United States | $0.194B | 0.00 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.34 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.108B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.87 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.93 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |